STOCK TITAN

Vanguard (HIMS) reports 0 shares after internal realignment — Schedule 13G/A

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed Amendment No. 5 to its Schedule 13G/A reporting on Hims & Hers Health Inc. common stock. The amendment states amount beneficially owned: 0 and percent of class: 0%, reflecting an internal realignment described as being made “in accordance with SEC Release No. 34-39538 (January 12, 1998).”

The filing explains certain subsidiaries or business divisions will report beneficial ownership separately after the realignment. The filing is signed by Ashley Grim, Head of Global Fund Administration.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

What does Vanguard report owning in HIMS on this Schedule 13G/A amendment?

It reports 0 shares and 0% ownership. The amendment states the holding is zero after an internal realignment and separate reporting by subsidiaries under SEC Release No. 34-39538.

Why does The Vanguard Group show zero ownership in the HIMS filing?

Because of an internal realignment completed January 12, 2026, causing subsidiaries to report separately. The filing cites SEC Release No. 34-39538 (January 12, 1998) as the basis for disaggregation.

Does the amendment identify any subsidiary beneficiaries or holdings for HIMS?

No specific subsidiary holdings are listed in this amendment. It states certain subsidiaries will report beneficial ownership separately but does not name those entities here.

Who signed the Schedule 13G/A amendment for Vanguard and when?

The filing is signed by Ashley Grim, Head of Global Fund Administration with a signature date of 03/27/2026 as shown in the filing excerpt.

Does this Schedule 13G/A amendment change Hims & Hers' outstanding share counts or company metrics?

No. The amendment only addresses Vanguard's reported beneficial ownership and internal reporting changes; it does not state any changes to Hims & Hers' outstanding shares or operating metrics.
Hims & Hers Health Inc

NYSE:HIMS

View HIMS Stock Overview

HIMS Rankings

HIMS Latest News

HIMS Latest SEC Filings

HIMS Stock Data

4.75B
205.99M
Drug Manufacturers - Specialty & Generic
Services-offices & Clinics of Doctors of Medicine
Link
United States
SAN FRANCISCO